Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.54 |
| ▸ | KDM5A | P29375 | 4/20 | 0.54 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.54 |
| ▸ | KDM5C | P41229 | 1/20 | 0.51 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.51 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8093289 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984529 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL28942179 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL448290 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16895244 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL41611 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984033 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL73050 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL10610457 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL27082196 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 560 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | claimed |
| WO-2024243322-A9 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| US-20250073319-A1 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | BIOMARIN PHARMACEUTICAL INC. | 2025-03-06 | — | — | US | claimed |
| WO-2024243322-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2024-11-28 | — | — | WO | claimed |
| US-20240392009-A1 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX INC (US) | 2024-11-28 | — | — | US | claimed |
| EP-4404980-A1 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | Inozyme Pharma, Inc. (US) | 2024-07-31 | — | — | EP | claimed |
| CN-118215507-A | Lyophilized ENPP1 polypeptide formulations and uses thereof | 依诺兹梅制药公司 | 2024-06-18 | — | — | CN | claimed |
| WO-2023049864-A1 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | INOZYME PHARMA, INC. (US) | 2023-03-30 | — | — | WO | claimed |
| CN-115721732-A | Pharmaceutical composition and preparation of antibody-conjugated drug, preparation method and application thereof | 上海复旦张江生物医药股份有限公司 | 2023-03-03 | — | — | CN | claimed |
| WO-2022079739-A1 | FIXED DOSE COMPOSITIONS OF CABOTEGRAVIR AND RILPIVIRINE | CIPLA LIMITED (IN) | 2022-04-21 | — | — | WO | claimed |
| US-6960353-B2 | Formulations for the transdermal administration of fenoldopam | ALZA CORPORATION (US) | 2005-11-01 | — | — | US | claimed |
| US-20040258742-A1 | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines | VAN OSDOL WILLIAM WOODSON (US) | 2004-12-23 | — | — | US | claimed |
| EP-1100476-B1 | FORMULATIONS FOR THE TRANSDERMAL ADMINISTRATION OF FENOLDOPAM | ALZA CORP (US) | 2004-06-16 | — | — | EP | claimed |
| US-20040057987-A1 | Novel formulations for the transdermal administration of fenoldopam | VAN OSDOL WILLIAM W (US) | 2004-03-25 | — | — | US | claimed |
| US-6699497-B1 | PERMEATION ENHANCER | ALZA CORPORATION | 2004-03-02 | — | — | US | claimed |
| US-20030198662-A1 | Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines | VAN OSDOL WILLIAM WOODSON (US) | 2003-10-23 | — | — | US | claimed |
| EP-1216036-A1 | TRANSDERMAL ADMINISTRATION OF N-(2,5-DISUBSTITUTED PHENYL)-N'-(3-SUBSTITUTED PHENYL)-N'-METHYL GUANIDINES | Alza Corporation (US) | 2002-06-26 | — | — | EP | claimed |
| EP-1100476-A1 | FORMULATIONS FOR THE TRANSDERMAL ADMINISTRATION OF FENOLDOPAM | ALZA CORPORATION (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2001019352-A1 | TRANSDERMAL ADMINISTRATION OF N-(2,5-DISUBSTITUTED PHENYL)-N'-(3-SUBSTITUTED PHENYL)-N'-METHYL GUANIDINES | ALZA CORPORATION (US) | 2001-03-22 | — | — | WO | claimed |
| WO-2000004886-A1 | FORMULATIONS FOR THE TRANSDERMAL ADMINISTRATION OF FENOLDOPAM | ALZA CORPORATION (US) | 2000-02-03 | — | — | WO | claimed |